Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Are you kidding? The stock price is where it is because O'Connor's reckless spending and misguided strategy was on path to drive the company into the ground. That is why he was fired, which was final confirmation the market needed that he had mismanaged the company and its finances. With the exception of Amgen, all his deals were weak giveaways with no money upfront. The final nail in his tenure was when, after alluding to a Europe deal, came to the spring 2017 annual meeting empty handed delivering nothing of value AND pushed through another shareholder unfriendly non-performance based bonus policy for management with auto escalations not needing shareholder approval. Over 40% of our shareholders voted against it (which is a huge number considering most almost always default to management recommendations), then we saw the mass exodus of our institutional investor base. And here we are hovering around the all time low stock price and valued at little more than cash, astonishing for a late stage company.